skinny.

Latest / Parkinson's Disease Education Podcast

Tavapadon and Parkinson's: A New Way to Stimulate Dopamine

Tavapadon is a new investigational medication for Parkinson's disease that works very differently from traditional dopamine agonists. Instead of broadly stimulating dopamine receptors, tavapadon selectively targets D1 receptors—the brain's primary "go" signal for movement—and does so as a partial agonist.

In this episode (watch on YouTube), I explain:

-How dopamine pathways actually work in Parkinson's disease

-Why most current dopamine agonists target D2 and D3 receptors

-What makes tavapadon's D1-selective mechanism unique

-How partial agonism may reduce receptor burnout and side effects…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.